Concepedia

Richard F. Dunne

RF

Statistics

Publications

40

Citations

4.9K

H-Index

25

Active since

1988

Affiliations

University of Rochester Medical Center(Current)

Brigham and Women's Hospital

The University of Texas MD Anderson Cancer Center

Harvard University

Dana-Farber Cancer Institute

Richard F. Dunne is an author at University of Rochester Medical Center specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1988–2025

40

Publications

40

Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy

Julio García‐Aguilar, Sujata Patil, Marc J. Gollub et al. · Journal of Clinical Oncology · 2022 · 823 citations · Full text

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Sun Young Rha, Do‐Youn Oh, Patricio Yañez et al. · The Lancet Oncology · 2023 · 521 citations

, , +8

Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study

Supriya G. Mohile, Mostafa Mohamed, Huiwen Xu et al. · The Lancet · 2021 · 513 citations · Full text

, , +7

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 364 citations

, , +10

Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma

Zhi Rong Qian, Douglas A. Rubinson, Jonathan A. Nowak et al. · JAMA Oncology · 2017 · 264 citations · Full text

1–5 of 40